Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KHK4827 in Moderate to Severe Plaque Psoriasis
NCT02982005Phase 3Completed
- Sponsor
- Kyowa Kirin
- Start
- Jan 2017
- Primary completion
- Aug 2018
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of brodalumab in plaque psoriasis, sponsored by Kyowa Kirin. Started Jan 2017; status: completed.
02
Drugs
brodalumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT02982005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02982005.